UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | D | G | H | K | M | P | R | S | T | W
Number of items: 24.

A

Ansell, BM; Woo, P; (1992) Enfermedades del Tejido connectivo en la infancia. In: Khamashta, MA and Font, J and Hughes, GRV, (eds.) Enfermedades autoimmunes del Tejido conectivo. (pp. 209-215). Ediciones Doyma SA: Barcelona, Spain.

B

Bedford, PA; Ansell, BM; Hall, PJ; Woo, P; (1992) Increased frequency of DR4 in systemic onset juvenile chronic arthritis. Clin.Exp.Rheumatol. , 10 (2) pp. 189-193.

Boucher, CA; Lange, JM; Miedema, FF; Weverling, GJ; Koot, M; Mulder, JW; Goudsmit, J; (1992) HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS , 6 (11) pp. 1259-1264.

Boucher, CA; O'Sullivan, E; Mulder, JW; Ramautarsing, C; Kellam, P; Darby, G; Lange, JM; (1992) Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. The Journal of Infectious Diseases , 165 (1) pp. 105-110.

D

David, J; Woo, P; (1992) Reactive amyloidosis. Arch.Dis.Child , 67 (3) pp. 258-261.

G

Gilson, RJC; Semple, M; Gill, SK; Loveday, C; Tedder, RS; Weller, IVD; (1992) Lack of suppression by ribavirin of HIV viraemia. (Letter). The Lancet , 339 pp. 1605-1606.

H

Harrison, TJ; Zuckerman, JN; Zuckerman, AJ; (1992) Viral Hepatitis. In: Strunin, L and Thomson, S, (eds.) The Liver and Anaesthesia. (pp. 795-817). Bailliere Tindall

K

Kellam, P; Boucher, CA; Larder, BA; (1992) Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. Proceedings of the National Academy of Sciences of the United States of America , 89 (5) pp. 1934-1938.

Kidd, IM; Emery, V; Griffiths, P; Pillay, D; (1992) Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus. Presented at: London Virology Discussion Group Annual Symposium, St Thomas’ Hospital, London.

Kinloch, S; Yerly, S; Perrin, L; Hirschel, B; Clumeck, N; Canton, P; Mathiesen, L; (1992) A prospective, randomised, placebo-controlled study of the treatment of primary HIV infection with zidovudine. Presented at: Third European Conference on Clinical Aspects and Treatment of HIV Infection, Paris, France.

Kinloch-de Loes, S; Masouye, I; Salomon, D; Harms, M; Chamot, E; Louis, O; Saurat, JH; (1992) Angiomatose bacillaire: a propos d'un cas. Schweizerische Medizinische Wochenschrift , 122 pp. 1168-1172.

M

Maini, M; French, P; Prince, M; Bingham, JS; (1992) Urethritis due to Neisseria meningitidis in a London genitourinary medicine clinic population. International Journal of STD and AIDS , 3 pp. 423-425.

P

Prentice, HG; Kibbler, CC; McWhinney, PH; (1992) Antimicrobial prophylaxis and treatment in the patient with bone marrow failure. In: Hoffbrand, AV and Brenner, M, (eds.) Recent Advances in Haematology 6. Churchill Livingstone: London.

R

Rieckhoff-Cantoni, L; Bernard, P; Didierjean, L; Imhof, K; Kinloch-de Loes, S; Saurat, JHK; S, ; (1992) Frequency of bullous pemphigoid-like antibodies as detected by western immunoblot analysis in pruritic dermatoses. Archives of Dermatology , 128 pp. 791-794.

S

Stylianou, E; O'Neill, LA; Rawlinson, L; Edbrooke, MR; Woo, P; Saklatvala, J; (1992) Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J.Biol.Chem. , 267 (22) pp. 15836-15841.

T

The Cefpirome Intensive Care Study Group, ; Davies, G; Edbrooke, AJ; Geddes, DL; Gould, AM; Gray, I; Miller, J; (1992) Cefpirome versus ceftazidime in the treatment of patients with serious infections in intensive care units: a multicentre, randomised comparative study. Presented at: 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy.

W

Watson, G; Coade, S; Woo, P; (1992) Analysis of the genomic and derived protein structure of a novel human serum amyloid A gene, SAA4. Scand.J.Immunol. , 36 (5) pp. 703-712.

Wilson, AP; (1992) What can Infection Control offer burn surgeons? Presented at: 6th International Society For Burn Injuries Conference.

Wilson, AP; Gruneberg, RN; (1992) Teicoplanin. In: Dollery, C, (ed.) Therapeutic Drugs Supplement 1. (pp. 194-199). Churchill Livingstone: Edinburgh.

Wilson, AP; Ridgway, GL; (1992) Intensive therapy units. In: Taylor, EW, (ed.) Infection and Surgical Practice. (pp. 292-299). Oxford University Press: Oxford.

Wilson, APR; (1992) Antibiotic Therapy in the Critically Ill. In: Tinker, J and Zapol, W, (eds.) Care of the Critically Ill Patient. (pp. 1146-1155). Springer Verlag: London.

Wilson, APR; Ridgway, GL; (1992) Scoring systems for surgical infection. Surgical Infection , 4 pp. 6-8.

Wilson, APR; Shrimpton, S; Jaderberg, M; (1992) A meta-analysis of the use of amoxycillin-clavulanic acid in surgical prophylaxis. Presented at: International Congress on the Management of Infection.

Woo, P; (1992) Amyloidosis in pediatric rheumatic diseases. J.Rheumatol.Suppl , 35 pp. 10-16.

This list was generated on Sun Nov 27 06:13:45 2016 GMT.